Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adrin Dadkhah

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Studies in Health Technology and Informatics|September 12, 2023
A Unified Data Architecture for Assessing Motor Symptoms in Parkinson's DiseaseChristopher Gundler, Qi Rui Zhu, Leona Trübe, et al.
European Journal of Haematology|November 6, 2022
Individualized busulfan dosing improves outcomes compared to fixed-dose administration in pre-transplant minimal residual disease-positive acute myeloid leukemia patients with intermediate-risk undergoing allogeneic stem cell transplantation in CREvgeny Klyuchnikov, Claudia Langebrake, Anita Badbaran, et al.
Bone Marrow Transplantation|September 13, 2024
A practical guide to therapeutic drug monitoring in busulfan: recommendations from the Pharmacist Committee of the European Society for Blood and Marrow Transplantation (EBMT)Vera Domingos, Katerina Nezvalova-Henriksen, Adrin Dadkhah, et al.
International Journal of Pharmaceutics|November 1, 2025
Expert opinion on extrusion-based pharmaceutical 3D printing from the European Society of Hospital Pharmaceutical Technology (GERPAC)Aisha A Ahmed, Kirsten J M Schimmel, Marija Tubic-Grozdanis, et al.
American Journal of Hematology|November 16, 2024
Clinical and Immune Effects of Peri-Transplantation JAK Inhibition for MyelofibrosisKristin Rathje, Nico Gagelmann, Anita Badbaran, et al.
Bone Marrow Transplantation|January 21, 2026
Impact of anti-T-lymphocyte globulin dosing on graft versus host disease in matched sibling peripheral blood stem cell transplantationRadwan Massoud, Evgeny Klyuchnikov, Silke Heidenreich, et al.
Bone Marrow Transplantation|October 1, 2025
Sequential versus standard conditioning in untreated MDS patients with blasts undergoing allogeneic HSCTRadwan Massoud, Evgeny Klyuchnikov, Normann Steiner, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Studies in Health Technology and Informatics|September 12, 2023
A Unified Data Architecture for Assessing Motor Symptoms in Parkinson's DiseaseChristopher Gundler, Qi Rui Zhu, Leona Trübe, et al.
European Journal of Haematology|November 6, 2022
Individualized busulfan dosing improves outcomes compared to fixed-dose administration in pre-transplant minimal residual disease-positive acute myeloid leukemia patients with intermediate-risk undergoing allogeneic stem cell transplantation in CREvgeny Klyuchnikov, Claudia Langebrake, Anita Badbaran, et al.
Bone Marrow Transplantation|September 13, 2024
A practical guide to therapeutic drug monitoring in busulfan: recommendations from the Pharmacist Committee of the European Society for Blood and Marrow Transplantation (EBMT)Vera Domingos, Katerina Nezvalova-Henriksen, Adrin Dadkhah, et al.
International Journal of Pharmaceutics|November 1, 2025
Expert opinion on extrusion-based pharmaceutical 3D printing from the European Society of Hospital Pharmaceutical Technology (GERPAC)Aisha A Ahmed, Kirsten J M Schimmel, Marija Tubic-Grozdanis, et al.
American Journal of Hematology|November 16, 2024
Clinical and Immune Effects of Peri-Transplantation JAK Inhibition for MyelofibrosisKristin Rathje, Nico Gagelmann, Anita Badbaran, et al.
Bone Marrow Transplantation|January 21, 2026
Impact of anti-T-lymphocyte globulin dosing on graft versus host disease in matched sibling peripheral blood stem cell transplantationRadwan Massoud, Evgeny Klyuchnikov, Silke Heidenreich, et al.
Bone Marrow Transplantation|October 1, 2025
Sequential versus standard conditioning in untreated MDS patients with blasts undergoing allogeneic HSCTRadwan Massoud, Evgeny Klyuchnikov, Normann Steiner, et al.
Pageof 2